Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
Cancer Treatment Reviews · 2026
DOI: 10.1016/j.ctrv.2026.103145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026. Verfasst von Irene Hernández de Córdoba Sánchez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Hospital Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Neoplasms, Epigenesis, Genetic, Protein-Arginine N-Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, University Hospital Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain.
- Department of Medical Oncology, University Hospital Fundación Jiménez Díaz, Moncloa-Aravaca, 28040 Madrid, Spain.
- START Madrid-FJD Early Phase Clinical Trials Unit, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
- Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: paloma_cejas@dfci.harvard.edu.
Zitieren
APA
de Córdoba Sánchez, I. H., Ruidiaz, M. A., Moreno, V., Long, H., & Cejas, P. (2026). Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2026.103145
Vancouver
de Córdoba Sánchez IH, Ruidiaz MA, Moreno V, Long H, Cejas P. Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors. Cancer Treatment Reviews. 2026. doi:10.1016/j.ctrv.2026.103145
BibTeX
@article{deCrdobaSnchez2026,
author = {de Córdoba Sánchez, Irene Hernández and Ruidiaz, Mercedes Avedillo and Moreno, Victor and Long, Henry and Cejas, Paloma},
title = {Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors},
journal = {Cancer Treatment Reviews},
year = {2026},
doi = {10.1016/j.ctrv.2026.103145}
}
EUVIMED